Audra Dalton

Title: Audra Dalton: Innovator in Pharmaceutical Compounds

Introduction

Audra Dalton is a prominent inventor based in Revere, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cell proliferative disorders, including cancer. With a total of 5 patents to her name, Dalton's work is paving the way for innovative treatments.

Latest Patents

Dalton's latest patents include the development of substituted tricyclic pyrazolo-pyrimidine compounds. This invention relates to methods of synthesizing these compounds and their use in pharmaceutical compositions for treating cell proliferative disorders. Another notable patent involves substituted indolo-pyridinone compounds, which also focus on methods of synthesis and their application in treating similar disorders.

Career Highlights

Audra Dalton is currently associated with Arqule, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Dalton collaborates with talented individuals in her field, including Mark Anthony Ashwell and Rocio Palma. These partnerships enhance her research capabilities and contribute to the innovative environment at Arqule, Inc.

Conclusion

Audra Dalton's contributions to pharmaceutical innovations are noteworthy, and her ongoing research promises to impact the treatment of serious health conditions. Her dedication to developing new compounds showcases the vital role of inventors in advancing medical science.